FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Biologics

Moderna Seeks Vaccine EUA for Kids 6 Months to 6 Years

Moderna is asking FDA for an emergency use authorization for its Covid-19 vaccine in children aged 6 months to 6 years old.

Human Drugs

Lillys Tirzepatide Meets Trial Weight Loss Endpoints

Lilly says its investigational weight-loss drug tirzepatide met all endpoints in the 72-week SURMOUNT-1 trial.

Human Drugs

FDA Lifts Hold on Pfizer Duchenne Gene Therapy

FDA lifts a clinical hold on Pfizers mini-dystrophin gene therapy, fordadistrogene movaparvovec, in ambulatory patients with Duchenne muscular dystrop...

Medical Devices

Risk Documents Key in Device Design: Column

Retired Ethicon quality engineer Eric Hinrichs says medical device project design teams must document all risk assessments and how the risks have been...

Human Drugs

McKinsey FDA Contract Under Fire at Hearing

A House Committee on Oversight and Reform hearing sharply criticizes consulting firm McKinsey and Co. for its role in advising Purdue Pharm during the...

Human Drugs

Current Merger Enforcement is Working: PhRMA

PhRMA cites FDA statistics to support its position that the Federal Trade Commission and Department of Justice dont need new ways to evaluate how drug...

Human Drugs

Pfizer Recalls 5 Accupril Lots

FDA says Pfizer is recalling five lots of Accupril due to the presence of a nitrosamine above the acceptable daily level.

Human Drugs

FDA Pushes Congress for Catalyst Decision Fix

FDA says it is interested in working with Congress to find a legislative solution, most likely a bill that would be added to the user fee reauthorizat...

Federal Register

Info Collection Revision on Expanded Access Form

Federal Register notice: FDA sends to OMB an information collection revision entitled Expanded Access to Investigational Drugs for Treatment Use.

Human Drugs

Janssen Sues to Block Counterfeit HIV Meds

Janssen asks a New York federal court to stop several drug wholesalers from selling counterfeit versions of the companys HIV drugs.